Form 4: Iveda Solutions CEO Ly Plans 175,000 Stock Option Grant
Planned Insider Transaction Report
Iveda Solutions CEO David H. Ly has filed a Form 4 indicating a planned acquisition of 175,000 stock options with an exercise price of $0.82, scheduled to vest immediately on December 29, 2025.
Summary
- David H. Ly, Chief Executive Officer and Director of Iveda Solutions, Inc. (IVDA), has reported a planned acquisition of 175,000 derivative securities in the form of stock options.
- The options are scheduled to be granted on December 29, 2025, with an exercise price of $0.82 per share.
- These options will vest 100% on the grant date, December 29, 2025.
- The options are set to expire on December 29, 2035.
- This transaction is being made pursuant to a Rule 10b5-1(c) plan, which allows insiders to pre-arrange trades.
- Following this planned transaction, Mr. Ly is expected to beneficially own 216,096 derivative securities.
Sentiment
Score: 7
Explanation: The planned grant of options to the CEO is generally a positive signal for management alignment with future company performance, though it represents a compensation event rather than a direct cash investment by the CEO.
Positives
- The planned grant of 175,000 stock options to CEO David H. Ly, under a Rule 10b5-1(c) plan, aligns management incentives with future shareholder interests.
- The options are scheduled to vest 100% on the grant date (December 29, 2025), indicating immediate ownership rights upon grant.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Planned grant of 175,000 stock options to David H. Ly, the Chief Executive Officer and Director of Iveda Solutions, Inc., with an exercise price of $0.82 per share, scheduled for December 29, 2025.
Stakeholder Impact
- Shareholders: Potential for increased share value due to aligned management incentives, balanced against potential future dilution if options are exercised.
- Management: Increased incentive to improve company performance due to direct equity interest.
Key Dates
| Date | Description |
|---|---|
| 12/29/2025 | Scheduled date of earliest transaction, grant date for options, and vesting date for options. |
| 12/31/2025 | Signature date of reporting person for this Form 4 filing. |
| 12/29/2035 | Expiration date of the planned options. |
Keywords
Iveda Solutions, IVDA, stock options, CEO, insider transaction, Form 4, beneficial ownership, executive compensation, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.